Preliminary lab studies show two doses of the Pfizer & BioNTech vaccine may not provide sufficient protection against the Omicron coronavirus variant, but three doses are able to neutralize it, the companies said in a news release on Wednesday.
The prophetical implications of all this aside for a moment, let's talk about the practical reason that big pharma companies like Pfizer, BioNTech, Moderna and the others have to keep the needle in your arm, money! Buckets and buckets of money that comes in at the rate of $1,000.00 USD per second. Remember back in the early days of 2020 where Bill Gates was vowing to fund 7 big pharma vaccine factories and then share the recipe with the whole world? Well, his statement was 50% true, he sure did give the 'seed money' to big pharma, and is now reaping the dividends. Bill Gates has never given even a single penny away, everything thing he has 'donated to' has been a shrewd, profit-bearing investment.
"For the love of money is the root of all evil: which while some coveted after, they have erred from the faith, and pierced themselves through with many sorrows. But thou, O man of God, flee these things; and follow after righteousness, godliness, faith, love, patience, meekness." 1 Timothy 6:10,11 (KJB)
Now the prophetical aspect all these vaccines have their roots, not in science, but in Pharmakeia, the Greek word for sorcery, witchcraft and magic. The president of Bayer Pharmaceuticals told you that mRNA is not a vaccine but a gene editing tool. You should believe him, I sure do. Pfizer says a third shot will give you 'good protection' from the Omicron variant, but guess what? Not taking any shots will give you 100% protection from Pfizer, BioNTech and Moderna.
Two vaccine doses may not provide sufficient protection against Omicron coronavirus variant, but protection improves with three doses, Pfizer says
FROM FAKE NEWS CNN: Samples from people who had two doses of the Covid-19 vaccine saw, on average, a more than 25-fold reduction in neutralization ability against the Omicron variant than the earlier virus, "indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant," the companies said. The companies said two doses may still provide protection against severe disease.
"Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it's clear from these preliminary data that protection is improved with a third dose of our vaccine," Pfizer Chairman and CEO Albert Bourla said in a statement. "Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19."
The initial lab studies used serum from blood from individuals who received two or three doses of the Pfizer/BioNTech Covid-19 vaccine. The sera was collected from subjects three weeks after their second dose, or one month after a third dose.
Pfizer and BioNTech are continuing to develop a variant-specific vaccine for Omicron and say it will be available by March, if it's needed. The data released Wednesday has not been peer-reviewed or published. READ MORE
No comments:
Post a Comment